Immunology News

Viral hepatitis kills thousands of people each year in the United States and causes more deaths worldwide than HIV, malaria and tuberculosis. Yet when experts traveled to Washington, D.C, last year to brief members of Congress about a national strategy to eliminate hepatitis B and C, they were met with a surprising lack of interest.

WASHINGTON — Beginning Friday, October 20, Healio Gastroenterology and Liver Disease will provide live coverage from the The Liver Meeting 2017.

AMSTERDAM — Understanding the impacts of fibrosis, drug–drug interactions with direct-acting antiviral therapies, and the pitfalls of immunosuppression can aid clinicians in treating liver transplantation candidates or recipients, according to data presented at the International Liver Congress.

A recent letter published in JAMA Internal Medicine reports two of nine human immune globulin products tested for hepatitis A prophylaxis efficacy just meet the minimal potency level required by the European Pharmacopeia.

Permanent drug withdrawal was an achievable treatment-free outcome and varied widely for patients with autoimmune hepatitis, according to a meta-analysis.

Members of the All-Party Parliamentary Hepatology Group have asked the National Health Service in the United Kingdom to show more concern about the rise of liver disease.

Hemodialysis patients with chronic kidney disease produce inferior immune responses to hepatitis B vaccine, with 41% of dialysis patients classified as nonresponders, results of a recent study revealed.

Acute renal failure better determined mortality rates in patients with cirrhosis and spontaneous bacterial peritonitis than renal impairment and end-stage renal disease in a recent study.

SAN FRANCISCO — A diet high in omega-3 fatty acids improved liver health in subjects with nonalcoholic fatty liver disease, according to a study presented here.